TP
Theravie Pharma, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$750Ksold at filing
Total offering$2.3M$1.5M still open
Investors in the raise1count reported to the SEC
FiledOct 19, 2026first sale Sep 29, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Samia Lina Helena AlmoughrabieExecutive Officer, Director
Richard Louis GalloExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.